Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide
Open Access
- 22 November 2016
- Vol. 21 (11) , 1582
Abstract
In this study, we synthesised a morpholino nucleoside-uridine (MNA-U) phosphoramidite and evaluated the potential of a MNA-modified antisense oligonucleotide (AO) sequences to induce exon 23 skipping in mdx mouse myotubes in vitro towards extending the applicability of morpholino chemistry with other nucleotide monomers. We designed, synthesised, and compared exon skipping efficiencies of 20 mer MNA-modified 2′-O-methyl RNA mixmer AO on a phosphorothioate backbone (MNA/2′-OMePS) to the corresponding fully modified 2′-O-methyl RNA AO (2′-OMePS) as a control. Our results showed that the MNA/2′-OMePS efficiently induced exon 23 skipping. As expected, the 2′-OMePS AO control yielded efficient exon 23 skipping. Under the applied conditions, both the AOs showed minor products corresponding to exon 22/23 dual exon skipping in low yield. As these are very preliminary data, more detailed studies are necessary; however, based on the preliminary results, MNA nucleotides might be useful in constructing antisense oligonucleotides.Keywords
This publication has 23 references indexed in Scilit:
- Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin GeneMolecular Therapy Nucleic Acids, 2012
- A U-Tetrad Stabilizes Human Telomeric RNA G-Quadruplex StructureJournal of the American Chemical Society, 2010
- Locked Nucleic Acids: Promising Nucleic Acid Analogs for Therapeutic ApplicationsChemistry & Biodiversity, 2010
- UNA (unlocked nucleic acid): A flexible RNA mimic that allows engineering of nucleic acid duplex stabilityBioorganic & Medicinal Chemistry, 2009
- Alternative splicing and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Molecular mechanisms of muscular dystrophies: old and new playersNature Reviews Molecular Cell Biology, 2006
- Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?Antisense and Nucleic Acid Drug Development, 2000
- Morpholino Antisense Oligomers: Design, Preparation, and PropertiesAntisense and Nucleic Acid Drug Development, 1997
- Peptide Nucleic Acids (PNA): Synthesis, properties and potential applicationsBioorganic & Medicinal Chemistry, 1996
- Spin Labeled Nucleoside Analogues: 4′-Hydroxymorpholin-2′-Ylpurines and PyrimidinesNucleosides and Nucleotides, 1993